Results 231 to 240 of about 26,692,564 (286)

Comparison of Alternative Outcome Measures in Cost-Effectiveness Analysis: Three Applications Within Oncology. [PDF]

Pharmacoeconomics
Reddy B, Telford C, Ambavane A, Mahajan S, Caro JJ.   +4 more
europepmc   +1 more source

A Simplified Laminar Flow Model for the Pultrusion of Glass Fiber/Polyethylene Terephthalate Commingled Yarns

Advanced Engineering Materials, EarlyView.
A simplified thermoplastic pultrusion model is developed to predict thermal fields in glass fiber/polyethylene terephthalate (GF/PET) composites with reduced computational cost. By combining effective material homogenization, validation against literature data, and Gaussian‐process‐based optimization, the study reveals how heating limits, pulling speed,
Elder Soares, Nadège Bouchonneau, Christian Jochum, Donald Radford   +3 more
wiley   +1 more source

Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy. [PDF]

Clinicoecon Outcomes Res
Panatto D, Bellone M, Castello L, Zanetta L, Piccolo A.   +4 more
europepmc   +1 more source

Affecting the Properties of Copper–Graphene Electroconductive Composite by Severe Plastic Deformation

Advanced Engineering Materials, EarlyView.
Copper‐based composites enhanced with carbon feature convenient mechanical properties and favorable electric conductivity. Processing via deformation and thermomechanical treatments can introduce advantageous microstructures further enhancing their performance. Herein, copper–graphene powder‐based composites are directly consolidated via rotary swaging
Radim Kocich, Lenka Kunčická, Pavel Czernek, Zifan Wang   +3 more
wiley   +1 more source

Tuberculosis infection tests for contact screening in Brazil: a cost-effectiveness analysis. [PDF]

Lancet Reg Health Am
Souza F, Steffen R, Pinto M, Nascimento do Prado T, Kritski AL, Trajman A.   +5 more
europepmc   +1 more source

Cost-Effectiveness Analysis of Ritlecitinib Compared With No Treatment in Patients With Severe Alopecia Areata in Japan. [PDF]

J Dermatol
Yuasa A, Kamei K, Saito S, Mikami M, Murata T, Kurosky SK, Law EH, Nakamura K, Ueki R.   +8 more
europepmc   +1 more source

Extended cost-effectiveness analysis in global health systems: a scoping review of geographic gaps and research trends. [PDF]

Cost Eff Resour Alloc
Najafi S, Moghadam MN, Amiresmaili MR, Barouni M, Haqhdoost AA, Sirizi MJ, Goudarzi R.   +6 more
europepmc   +1 more source

Optimizing PD-1/PD-L1 inhibitors plus chemotherapy for driver mutation-negative non-squamous NSCLC in China: a cost-effectiveness analysis. [PDF]

Front Pharmacol
Ji J, Du Q, Teng M, Qin F, Zhang R, Dong Y.   +5 more
europepmc   +1 more source

Cost-effectiveness analysis of disitamab vedotin plus toripalimab versus chemotherapy as treatment for HER2-expressing advanced urothelial cancer in China. [PDF]

BMJ Open
Jia Y, Zhu L, Kang S, Wang X.
europepmc   +1 more source